IRENE PADRE: Open Payments
NPI 1245453703 · WEST ORANGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,970 in 54 payments from 22 companies in 2025. Trend: 2023 $765 · 2024 $971 · 2025 $1,970
Grant: $1,000Food & beverage: $970
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 1 | $1,000 |
| Boston Scientific Corporation | 6 | $107 |
| Regeneron Healthcare Solutions, Inc. | 5 | $92 |
| BridgeBio Pharma, Inc. | 4 | $76 |
| Merck Sharp & Dohme LLC | 4 | $70 |
| Impulse Dynamics (USA) Inc. | 3 | $59 |
| SCPHARMACEUTICALS INC. | 3 | $52 |
| Edwards Lifesciences Corporation | 2 | $47 |
| Alnylam Pharmaceuticals Inc. | 3 | $46 |
| Amgen Inc. | 3 | $46 |
Products named: WATCHMAN FLX, EVKEEZA, Attruby, Optimizer, FUROSCIX, VERQUVO, ONPATTRO, Repatha.
Industry payments across NJ — which companies pay providers there.
